Skip to main content
Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
3.930
+0.130 (3.42%)
Nov 21, 2024, 1:56 PM EST - Market open

Nexalin Technology Revenue

Nexalin Technology had revenue of $36.03K in the quarter ending September 30, 2024, with 49.43% growth. This brings the company's revenue in the last twelve months to $162.08K, up 26.00% year-over-year. In the year 2023, Nexalin Technology had annual revenue of $110.75K, down -91.62%.

Revenue (ttm)
$162.08K
Revenue Growth
+26.00%
P/S Ratio
194.93
Revenue / Employee
$27,013
Employees
6
Market Cap
41.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023110.75K-1.21M-91.62%
Dec 31, 20221.32M1.18M817.20%
Dec 31, 2021144.07K-98.85K-40.69%
Dec 31, 2020242.91K35.53K17.13%
Dec 31, 2019207.38K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
iCAD, Inc. 18.94M
Accelerate Diagnostics 11.91M
Omega Therapeutics 8.10M
LAVA Therapeutics 7.40M
HCW Biologics 3.50M
VYNE Therapeutics 493.00K
Daxor 154.21K
Revenue Rankings

NXL News

More News